Focal Point Pharmaceuticals' Unattributed VC - II Round

Focal Point Pharmaceuticals raised a round of funding on January 31, 2017. Investors include MB Venture Partners.

Focal Point Pharmaceuticals is an early stage company developing products for ocular diseases. The aim of the company is to provide new therapeutics for rare diseases that would be granted orphan stat…

Articles about Focal Point Pharmaceuticals' Unattributed VC - II Round: